UFP Technologies, Inc.

UFPT Healthcare Medical Devices

UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024. In the quarter to June 2026, revenue grew 15.1%, EPS grew 20.6%, free cash flow fell 35.8% and total debt fell 19.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

291.67 5.52 −1.86%
Market cap
$2.3B
P/E
31.2×
Fwd P/E
23.6×
Dividend yield
—
F-score
5/9
Altman Z
6.86
Beneish M
−2.57
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

18.31% 17.82% 17.17% 17.05%
Piotroski F-Score
6 5 5 4
ROA
10.40% 10.64% 10.42% 10.98%
ROIC
10.65% 10.44% 10.15% 10.29%
Return on Tangible Assets
34.73% 33.28% 30.43% 30.96%
Average Days of Receivables
53.10 53.42 61.48 67.82
Free Cash Flow per Share
11.34 10.26 9.01 7.95
Free Cash Flow
87.47 79.03 69.55 61.50
Other line items

Show all line items

Columns are period end dates